Comparison between Sheel Biotech IPO and Vijaypd Ceutical IPO.
Sheel Biotech IPO is a SME Fixed Price IPO proposed to list at NSE SME while Vijaypd Ceutical IPO is a SME Fixed Price proposed to list at NSE SME.
| Sheel Biotech IPO | Vijaypd Ceutical IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Smart Horizon Capital Advisors Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Mansi Share & Stock Broking Pvt.Ltd. | Shreni Shares Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Sheel Biotech IPO is up to ₹32.31 Cr whereas the issue size of the Vijaypd Ceutical IPO is up to ₹18.26 Cr. The final issue price of Sheel Biotech IPO is ₹63.00 per share and of Vijaypd Ceutical IPO is ₹35.00 per share.
| Sheel Biotech IPO | Vijaypd Ceutical IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹59.00 per share | |
| Issue Price (Upper) | ₹63.00 per share | |
| Issue Price (Final) | ₹63.00 per share | ₹35.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 4000 shares |
| Fresh Issue Size | 51,28,000 shares | 52,16,000 shares |
| Fresh Issue Size (Amount) | up to ₹32.31 Cr | up to ₹18.26 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 51,28,000 shares | 52,16,000 shares |
| Issue Size Total (Amount) | up to ₹32.31 Cr | up to ₹18.26 Cr |
Sheel Biotech IPO opens on Sep 30, 2025, while Vijaypd Ceutical IPO opens on Sep 29, 2025. The closing date of Sheel Biotech IPO and Vijaypd Ceutical IPO is Oct 03, 2025, and Oct 01, 2025, respectively.
| Sheel Biotech IPO | Vijaypd Ceutical IPO | |
|---|---|---|
| Anchor Bid Date | Sep 29, 2025 | |
| Issue Open | Sep 30, 2025 | Sep 29, 2025 |
| Issue Close | Oct 03, 2025 | Oct 01, 2025 |
| Basis Of Allotment (Tentative) | Oct 06, 2025 | Oct 03, 2025 |
| Initiation of Refunds (Tentative) | Oct 07, 2025 | Oct 06, 2025 |
| Credit of Share (Tentative) | Oct 07, 2025 | Oct 06, 2025 |
| Listing date (Tentative) | Oct 08, 2025 | Oct 07, 2025 |
| Anchor Lockin End date 1 | Nov 05, 2025 | |
| Anchor Lockin End date 2 | Jan 04, 2026 |
Sheel Biotech IPO P/E ratio is 8.86, as compared to Vijaypd Ceutical IPO P/E ratio of .
| Sheel Biotech IPO | Vijaypd Ceutical IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Sheel Biotech Ltd.'s revenue increased by 11% and profit after tax (PAT) rose by 2% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Vijaypd Ceutical Ltd.'s revenue increased by 98% and profit after tax (PAT) rose by 191% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 96.99 | 78.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.26 | 56.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 8.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹128.22 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 13.59 | 28.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 16.34 | 17.30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.21 | 0.68 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 13.59 | 14.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Sheel Biotech IPO Retail Individual Investors (RII) are offered 18,04,000 shares while in Vijaypd Ceutical IPO retail investors are offered 18,04,000 shares. Qualified Institutional Buyers (QIB) are offered 10,26,000 shares in Sheel Biotech IPO and 0 shares in Vijaypd Ceutical IPO.
| Sheel Biotech IPO | Vijaypd Ceutical IPO | |
|---|---|---|
| Anchor Investor Reservation | 15,24,000 shares | 0 shares |
| Market Maker Reservation | 2,72,000 shares | 2,84,000 shares |
| QIB | 10,26,000 shares | 0 shares |
| NII | 7,74,000 shares | 26,08,000 shares |
| RII | 18,04,000 shares | 26,08,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 51,28,000 shares | 52,16,000 shares |
Sheel Biotech IPO subscribed 15.97x in total, whereas Vijaypd Ceutical IPO subscribed 1.37x.
| Sheel Biotech IPO | Vijaypd Ceutical IPO | |
|---|---|---|
| QIB (times) | 19.73x | |
| NII (times) | 25.92x | 1.86x |
| Big NII (times) | 31.64x | |
| Small NII (times) | 14.49x | |
| RII (times) | 9.56x | 0.89x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 15.97x | 1.37x |
